Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer.
Treatment of non-small cell lung cancer (NSCLC) with radiotherapy or chemoradiotherapy is often accompanied by the development of esophagitis and pneumonitis. Identifying patients who might be at increased risk for normal tissue toxicity would help in determination of the optimal radiation dose to avoid these events. We profiled 59 single nucleotide polymorphisms (SNPs) from 37 inflammation-related genes in 173 NSCLC patients with stage IIIA/IIIB (dry) disease who were treated with definitive radiation or chemoradiation. For esophagitis risk, nine SNPs were associated with a 1.5- to 4-fold increase in risk, including three PTGS2 (COX2) variants: rs20417 (HR:1.93, 95% CI:1.10-3.39), rs5275 (HR:1.58, 95% CI:1.09-2.27), and rs689470 (HR:3.38, 95% CI:1.09-10.49). Significantly increased risk of pneumonitis was observed for patients with genetic variation in the proinflammatory genes IL1A, IL8, TNF, TNFRSF1B, and MIF. In contrast, NOS3:rs1799983 displayed a protective effect with a 45% reduction in pneumonitis risk (HR:0.55, 95% CI:0.31-0.96). Pneumonitis risk was also modulated by polymorphisms in anti-inflammatory genes, including genetic variation in IL13. rs20541 and rs180925 each resulted in increased risk (HR:2.95, 95% CI:1.14-7.63 and HR:3.23, 95% CI:1.03-10.18, respectively). The cumulative effect of these SNPs on risk was dose-dependent, as evidenced by a significantly increased risk of either toxicity with an increasing number of risk genotypes (P<0.001). These results suggest that genetic variations among inflammation pathway genes may modulate the development of radiation-induced toxicity and, ultimately, help in identifying patients who are at an increased likelihood for such events.
Hildebrandt
Michelle A T
MA
Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Komaki
Ritsuko
R
Liao
Zhongxing
Z
Gu
Jian
J
Chang
Joe Y
JY
Ye
Yuanqing
Y
Lu
Charles
C
Stewart
David J
DJ
Minna
John D
JD
Roth
Jack A
JA
Lippman
Scott M
SM
Cox
James D
JD
Hong
Waun Ki
WK
Spitz
Margaret R
MR
Wu
Xifeng
X
D000483:Alleles; D002289:Carcinoma, Non-Small-Cell Lung / Q000235:genetics* / Q000532:radiotherapy*; D004941:Esophagitis / Q000209:etiology / Q000235:genetics; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D007249:Inflammation / Q000235:genetics*; D008175:Lung Neoplasms / Q000235:genetics* / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D011832:Radiation Injuries / Q000209:etiology / Q000235:genetics*; D017564:Radiation Pneumonitis / Q000209:etiology / Q000235:genetics; D016019:Survival Analysis
Arterioscler Thromb Vasc Biol. 2002 Oct 1;22(10):1631-6
12377741
Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1399-407
16997503
Radiother Oncol. 2005 Apr;75(1):18-21
15878096
Radiother Oncol. 2002 Aug;64(2):131-40
12242122
Immunogenetics. 2007 Jun;59(6):441-8
17440718
Int J Radiat Oncol Biol Phys. 1994 Feb 1;28(3):621-31
8113105
Pediatr Allergy Immunol. 2009 Mar;20(2):157-63
18811622
Hum Mol Genet. 2002 May 15;11(11):1281-9
12019209
Radiother Oncol. 2003 Nov;69(2):127-35
14643949
Carcinogenesis. 2009 Feb;30(2):295-9
19073878
J Hypertens. 2002 Oct;20(10):2023-7
12359981
Radiother Oncol. 2009 Jun;91(3):282-7
18950881
N Engl J Med. 2004 Jan 22;350(4):379-92
14736930
Chest. 2000 Aug;118(2):503-8
10936147
J Clin Invest. 2005 Mar;115(3):747-54
15711639
Int J Radiat Biol. 2003 Feb;79(2):137-43
12569017
Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):89-94
10924976
J Biol Chem. 2000 Jun 16;275(24):18138-44
10747905
Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):568-74
18793959
CA Cancer J Clin. 2000 Jan-Feb;50(1):7-33
10735013
Genes Immun. 2001 Apr;2(2):105-9
11393654
N Engl J Med. 1997 Dec 11;337(24):1720-5
9392697
Nat Rev Cancer. 2009 Feb;9(2):134-42
19148183
Thorax. 2000 Dec;55(12):1023-7
11083887
Int J Radiat Oncol Biol Phys. 1995 Aug 30;33(1):99-109
7642437
J Clin Periodontol. 2003 Jun;30(6):524-31
12795791
Int J Radiat Oncol Biol Phys. 2003 Feb 1;55(2):337-41
12527046
Ann Med. 2009;41(2):128-38
18752089
J Allergy Clin Immunol. 2007 Mar;119(3):687-96
17208287
J Immunol. 2006 Dec 15;177(12):8633-42
17142763
Tissue Antigens. 1998 Jun;51(6):605-12
9694352
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
18287387
Chest. 2000 Apr;117(4):1162-72
10767254
Cancer Res. 2007 Jul 1;67(13):6520-7
17596594
J Immunol. 2003 Jun 1;170(11):5578-82
12759436
Arthritis Rheum. 1999 Jun;42(6):1101-8
10366102
Arthritis Rheum. 2001 Dec;44(12):2819-27
11762942
J Allergy Clin Immunol. 2003 Nov;112(5):893-8
14610476
Semin Radiat Oncol. 2003 Jul;13(3):176-81
12903007
Cytokine. 2007 Oct;40(1):17-22
17869127
J Biol Chem. 2005 Feb 18;280(7):5994-6004
15572357
Scand J Immunol. 2006 Aug;64(2):164-9
16867162
FEBS Lett. 2000 Apr 7;471(1):45-50
10760510
Am J Respir Crit Care Med. 2006 Oct 15;174(8):915-22
16840740
Immunogenetics. 2002 May;54(2):82-6
12037600
Curr Pharm Des. 2004;10(6):635-46
14965326